Wall Street Analysts Predict a 44.79% Upside in Arcutis Biotherapeutics (ARQT): Here's What You Should Know

Arcutis Biotherapeutics, Inc. (ARQT) closed the last trading session at $15.63, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $22.63 indicates a 44.8% upside potential.The average comprises eight short-term price targets ranging from a low of $18.00 to a high of $29.00, with a standard deviation of $3.25. While the lowest estimate indicates an increase of 15.2% from ...